Latest News

Tutor Perini (NYSE:TPC) reports strong operational recovery with better cash flow and margin performance. The company posts a sharp improvement in quarterly EPS growth alongside healthier free cash flow. These operational shifts point to a business that is running more efficiently and generating stronger results from existing projects. Tutor Perini’s recent progress comes with the stock trading at $85.87, after a 4.4% gain over the past week and 13.0% over the past month. The move adds to a...

Avidity Biosciences (RNA) has wrapped up FY 2025 with fourth quarter revenue of about US$0.9 million, a basic EPS loss of US$1.54 and a net loss of roughly US$237.1 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q3 2024 to US$12.5 million in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q3 2024 to a loss of US$1.27 in Q3 2025, and trailing 12 month EPS landed at a loss of US$4.97. This sets the stage for a results season where investors are...

Vysarn (ASX:VYS) has put up another solid reporting period, with H1 2026 results framed by trailing 12 month revenue of about A$132.3 million, net income of roughly A$14.4 million and basic EPS of A$0.027213. The company has seen revenue move from A$37.0 million in H2 2024 to A$41.0 million in H1 2025 and then A$65.5 million in H2 2025, while basic EPS over those halves stepped from A$0.009416 to A$0.0075 and then A$0.013513, setting up the current trailing profile. With net profit margins...

Targa Resources (NYSE:TRGP) announced a major build out of natural gas processing plants in the Permian Basin. The company is adding a new large scale NGL fractionator, Train 13, at its Mont Belvieu complex. Targa outlined additional growth projects, including carbon capture initiatives and AI driven technology upgrades across its system. The expansion is described as aimed at meeting rising energy demand tied to data centers and broader market needs. Targa Resources, a large midstream...

Cogent Biosciences (NasdaqGS:COGT) has advanced its lead therapy bezuclastinib into a Phase 3 trial for systemic mastocytosis. The company has also filed a significant shelf registration that could be used to raise capital in the future. These updates highlight progress in Cogent Biosciences' clinical pipeline alongside preparations for potential funding needs. Cogent Biosciences enters this news cycle with its shares at $39.18 and very large 1 year returns, reflecting strong recent...

Great Lakes Dredge & Dock (GLDD) capped FY 2025 with Q4 revenue of US$256.5 million and basic EPS of US$0.19, rounding out a trailing twelve month picture that includes total revenue of US$888.3 million and EPS of US$1.10. Over the past few quarters, the company has seen revenue move from US$191.2 million in Q3 2024 to US$202.8 million in Q4 2024, then to US$242.9 million in Q1 2025 and US$195.2 million in Q3 2025, with quarterly EPS ranging from US$0.13 to US$0.50 over the same stretch. This...

China Yuchai International (NYSE:CYD) has just posted its FY 2025 first half numbers, with revenue of C¥13.8b and basic EPS of C¥9.75, setting the tone for a year in which investors are closely tracking how earnings and sales are holding up. The company has seen revenue move from C¥10.3b in the first half of 2024 to C¥13.8b in the first half of 2025, while basic EPS went from C¥5.88 to C¥9.75 over the same period. With trailing 12 month EPS at C¥14.32 on revenue of C¥24.7b, the results put...

Expand Energy has partnered with Evolution Well Services to deploy 100% electric hydraulic fracturing technology in Northeast Appalachia. The initiative targets lower noise, a smaller equipment footprint, reduced surface disruption, and real time environmental monitoring. The move reflects a focus on operational efficiency and environmental performance that has not featured in recent company updates. For investors watching Expand Energy (NasdaqGS:EXE), this partnership adds a fresh...

Clearway Energy (CWEN.A) just closed out FY 2025 with Q4 revenue of US$310 million and a basic EPS loss of US$0.85, capping a trailing twelve month period that totaled US$1.4 billion of revenue and US$1.42 in basic EPS. The company has seen quarterly revenue move from US$256 million in Q4 2024 to US$310 million in Q4 2025. Over the same period, basic EPS shifted from US$0.03 to a loss of US$0.85, against a backdrop of trailing twelve month net income of US$169 million. For investors, that mix...

Navigator Global Investments (ASX:NGI) has put fresh numbers on the table for H1 2026, with total revenue for H2 2025 at US$48 million and basic EPS of US$0.09, alongside trailing 12 month revenue of US$150.7 million and EPS of US$0.08. Over recent halves, the company has seen revenue move from US$48 million in H2 2024 to US$75.2 million in H1 2025 and US$48 million in H2 2025, while basic EPS shifted from US$0.10 to US$0.13 and then US$0.09. This sets up a mixed but data rich picture for...

PlaySide Studios reported half-year results to 31 December 2025, with sales of A$20.41 million and net income of A$7.94 million, reversing the prior period’s loss. Despite lower sales than a year earlier, the swing from a basic loss per share of A$0.013 to earnings of A$0.0179 highlights a marked turnaround in profitability and cost control. With PlaySide’s shift from a net loss to profit now on record, we’ll explore how this earnings turnaround reshapes its investment narrative. We've...

Symal Group (ASX:SYL) has drawn fresh attention after releasing half year results to 31 December 2025, reporting A$499.38 million in sales, A$504.2 million in revenue, and A$19.29 million in net income. See our latest analysis for Symal Group. Despite the strong half year earnings update, Symal Group’s recent share price performance has been weak, with a 7 day share price return showing a 23.25% decline and a year to date share price return showing a 30.55% decline from A$2.41, while its 1...

THOR Industries (NYSE:THO) has reorganized its North American RV operations to create two new operating groups focused on alignment and efficiency. The company announced related executive leadership changes as part of this restructuring. The move is intended to reshape how THOR coordinates its brands and manages its RV segment across North America. THOR Industries, a major manufacturer in the recreational vehicle space, sits at the center of a sector that is closely tied to consumer...

Teekay Tankers (NYSE:TNK) has moved ahead with a major fleet renewal, adding newer vessels and selling older ships. The company is acting during one of the strongest spot rate markets for crude and product tankers in more than ten years. Management is reshaping the fleet while global trade routes shift in response to sanctions and changing seaborne flows. Teekay Tankers focuses on transporting crude oil and refined products across key global shipping routes. The latest fleet moves come as...

Surge Energy Inc. recently affirmed a cash dividend of C$0.043333 per share, payable on March 16, 2026, to shareholders of record as of February 28, 2026, for February 2026 production. This confirmation underlines the company’s ongoing use of regular cash distributions as a core element of how it returns capital to investors. We’ll now explore how this confirmed cash dividend shapes Surge Energy’s investment narrative, particularly its approach to consistent shareholder returns. Outshine the...

Viva Energy Group (ASX:VEA) has put a tough set of FY 2025 numbers on the table, with first half revenue of A$14.9b alongside a basic EPS loss of A$0.12 and a net loss of A$195.4m, keeping margins in the red. The company has seen revenue move from A$14.4b in 1H 2024 to A$15.8b in 2H 2024 and then A$14.9b in 1H 2025, while EPS shifted from A$0.05 in 1H 2024 to a loss of A$0.10 in 2H 2024 and a deeper loss of A$0.12 in the latest half. This sets up a results season in which investors will be...

If you are wondering whether EVERTEC's current share price still reflects its true potential, or if the market has marked it down too far, this article is for you. With EVERTEC's share price at US$25.78 and share price returns of a 2.2% decline over 7 days, 13.5% decline over 30 days, 10.1% decline year to date, 21.4% decline over 1 year, 29.3% decline over 3 years and 28.1% decline over 5 years, many investors are asking what the stock is really worth now. Recent coverage has focused on...

What recent returns say about QMMM Holdings (QMMM) QMMM Holdings (QMMM) has attracted attention after a 19.4% one day move, a return of 19.4% over the past 3 months, and a year to date gain of 87.44%. See our latest analysis for QMMM Holdings. That surge in the 1 day share price return and the latest share price of $119.4 comes on top of a 90 day share price return of 19.4% and a very large year to date share price gain. The 1 year total shareholder return is also very large, suggesting...

How Cuscal (ASX:CCL) Entered H1 2026 Cuscal (ASX:CCL) has opened H1 2026 with a steady earnings base, coming off H2 2025 net income of A$16.5 million on revenue of A$243.1 million, alongside trailing 12 month EPS of A$0.197324 on A$516.1 million in revenue and A$38 million in net income. The company has seen revenue move from A$247.4 million in H2 2024 to A$249.4 million in H1 2025 and then A$243.1 million in H2 2025. Over the same periods, basic EPS shifted from A$0.102052 to A$0.068347 and...

Iluka Resources has reported past full-year 2025 results, with sales of A$1,015.4 million and a net loss of A$288.4 million, alongside a fully franked ordinary dividend of A$0.03 per security for the six months ended 31 December 2025. The swing from profit to loss and the lower dividend signal pressure on earnings quality and cash returns at a time of ongoing project investment. We’ll now examine how this move into a full-year loss and reduced dividend reshapes Iluka’s investment narrative...

Scentre Group (ASX:SCG) has posted its FY 2025 first half results with funds from operations of A$586.6 million, total revenue of A$1.3 billion and basic EPS of A$0.15, setting the tone for how investors will read the latest move in its earnings profile. The group has seen revenue move from A$1.28 billion in 1H 2024 to A$1.31 billion in 2H 2024 and A$1.31 billion in 1H 2025, while basic EPS shifted from A$0.08 to A$0.12 and then A$0.15 over the same periods. Trailing 12 month net profit...

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...

Wondering whether Enel’s share price still offers value after a strong run, or if the easy gains are behind it? This article walks through what the current price actually implies. Enel recently closed at €9.80, with returns of 6.2% over 7 days, 8.7% over 30 days, 8.9% year to date, 48.6% over 1 year and 121.8% over 3 years. This naturally raises questions about how much upside or downside is now priced in. Recent coverage around Enel has focused on its role as a major European utility and...

Vulcan Steel (ASX:VSL) has reported its H1 2026 results with total revenue of NZ$455.2 million and basic EPS of NZ$0.0497, alongside trailing 12 month revenue of NZ$990.5 million and EPS of NZ$0.1097. The company has seen revenue move from NZ$500.3 million and EPS of NZ$0.1056 in H2 2024 to NZ$492.99 million and EPS of NZ$0.0698 in H1 2025, before landing at the latest half year numbers, giving investors a clear view of how the top line and per share earnings have tracked across recent...